Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises DNB Liv Eiendom Sverige AB
Mandate

Vinge advises DNB Liv Eiendom Sverige AB

February 04, 2013

Vinge has advised DNB Liv Eiendom Sverige AB in connection with the sale of the modern office premises, Flundran 2 located at Universitetsholmen in Malmö. The Court of Appeal for Skåne and Blekinge is located at these premises.  The buyer is Vasce AB and the purchase price is SEK 361 million. 

Vinge’s team consisted of partner Patrick Forslund and associate Niclas Winnberg.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025